Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice
- 1 January 2013
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 698 (1-3) , 252-258
Abstract
No abstract availableKeywords
Funding Information
- NIH (MH092970, MH038752)
This publication has 36 references indexed in Scilit:
- The effects of clozapine on the GSK‐3‐mediated signaling pathwayFEBS Letters, 2004
- The glamour and gloom of glycogen synthase kinase-3Trends in Biochemical Sciences, 2004
- National Trends in the Treatment of Attention Deficit Hyperactivity DisorderAmerican Journal of Psychiatry, 2003
- AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim testInternational Journal of Neuropsychopharmacology, 1999
- Association and Linkage of the Dopamine Transporter Gene and Attention-Deficit Hyperactivity Disorder in Children: Heterogeneity owing to Diagnostic Subtype and SeverityThe American Journal of Human Genetics, 1998
- Effects of Methylphenidate on Extracellular Dopamine, Serotonin, and Norepinephrine: Comparison with AmphetamineJournal of Neurochemistry, 1997
- PNU-96415E, a Potential Antipsychotic Agent with Clozapine-Like Pharmacological PropertiesThe Journal of Pharmacology and Experimental Therapeutics, 1997
- Attention Deficit Disorder: A Review of the Past 10 YearsJournal of the American Academy of Child & Adolescent Psychiatry, 1996
- Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transportersLife Sciences, 1996
- Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transportThe Journal of Neuroscience, 1995